Quick Answer
Cytosorbents Corp reported Total Assets of $44.18 million for fiscal year 2025.
Cytosorbents Corp Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $44.18M | -6.7% |
| 2024 | $47.37M | -0.9% |
| 2024 | $47.80M | -10.5% |
| 2024 | $53.43M | +13.5% |
| 2024 | $47.07M | -11.1% |
| 2023 | $52.96M | +11.3% |
| 2023 | $47.58M | -9.3% |
| 2023 | $52.44M | -8.7% |
| 2023 | $57.46M | -9.1% |
| 2022 | $63.23M | -29.4% |
| 2021 | $89.52M | -0.5% |
| 2020 | $89.95M | +228.5% |
| 2019 | $27.38M | -19.9% |
| 2018 | $34.20M | +41.9% |
| 2017 | $24.10M | +148.6% |
| 2016 | $9.69M | -13.9% |
| 2015 | $11.25M | +32.9% |
| 2014 | $8.47M | +109.3% |
| 2013 | $4.05M | +21.2% |
| 2012 | $3.34M | +57.3% |
| 2011 | $2.12M | +17.1% |
| 2010 | $1.81M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $45.75M | -4.3% | -4.7% |
| June 30, 2025 | $47.99M | -10.2% | -5.5% |
| March 31, 2025 | $50.78M | +7.9% | +7.2% |
| December 31, 2024 | $47.37M | -11.1% | -0.9% |
| September 30, 2024 | $47.80M | +0.5% | -10.5% |
| June 30, 2024 | $53.43M | +1.9% | +13.5% |
| March 31, 2024 | $47.07M | -18.1% | -11.6% |
| December 31, 2023 | $53.26M | -15.8% | +12.0% |
- Cytosorbents Corp showed a decrease of -6.7% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, Cytosorbents Corp’s total assets has grown by 2338.4% (from $1.81 million to $44.18 million).
- The most recent figure is from Cytosorbents Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: